MedTrace Logo

Effect of Quercetin on Prophylaxis and Treatment of COVID-19

NCT04377789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 447

Last updated 2021-02-18

No results posted yet for this study

Summary

Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19 goes with excessive immune reaction of human body in severe cases. The investigators hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be effective on both prophylaxis and treatment of COVID-19 cases. Therefore, the aim of this study to evaluate the possible role of quercetin on prophylaxis and treatment of COVID-19.

Conditions

Interventions

DIETARY_SUPPLEMENT

Quercetin Prophylaxis

a daily dose of quercetin (500mg) will be taken by non-COVID-19 intervention group 1

DIETARY_SUPPLEMENT

Quercetin Treatment

a daily dose of quercetin (1000mg) will be taken by proven COVID-19 cases intervention group 2

Sponsors & Collaborators

  • Orbiteratec (funding)

    collaborator UNKNOWN

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-07-31
Completion
2020-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377789 on ClinicalTrials.gov